MAPK regulation of IL-4/IL-13 receptors contributes to the synergistic increase in CCL11/eotaxin-1 in response to TGF-β1 and IL-13 in human airway fibroblasts

Journal of Immunology

Volumn 188, Issue 12, 2012, Pages 6046-6054

  Zhou, Xiuxia ^a,b   Hu, Haizhen ^a,b   Balzar, Silvana ^a,b   Trudeau, John B ^a,b   Wenzel, Sally E ^a,b  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; EOTAXIN; INTERLEUKIN 13; INTERLEUKIN 13 RECEPTOR; INTERLEUKIN 13 RECEPTOR ALPHA2; INTERLEUKIN 4 RECEPTOR; INTERLEUKIN 4 RECEPTOR ALPHA; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; SMALL INTERFERING RNA; STAT6 PROTEIN; TRANSFORMING GROWTH FACTOR BETA1;

AIRWAY; ARTICLE; ASTHMA; AUTOREGULATION; CELL NUCLEUS; CELL STIMULATION; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME REGULATION; EOSINOPHILIA; FIBROBLAST CULTURE; GENE EXPRESSION; GENE SILENCING; HUMAN; HUMAN CELL; INTRACELLULAR TRANSPORT; NEGATIVE FEEDBACK; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN PROCESSING; RNA STABILITY; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION; UPREGULATION;

ASTHMA; BLOTTING, WESTERN; CHEMOKINE CCL11; CHROMATIN IMMUNOPRECIPITATION; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FIBROBLASTS; FLUORESCENT ANTIBODY TECHNIQUE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HUMANS; INFLAMMATION; INTERLEUKIN-13; LUNG; RECEPTORS, INTERLEUKIN-13; RECEPTORS, INTERLEUKIN-4; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; STAT6 TRANSCRIPTION FACTOR; TRANSFORMING GROWTH FACTOR BETA1;

EID: 84862596925     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1102760     Document Type: Article

References (52)

1. Blobe, G. C., W. P. Schiemann, and H. F. Lodish. 2000. Role of transforming growth factor b in human disease. N. Engl. J. Med. 342: 1350-1358. (Pubitemid 30408720)
2. Doherty, T., and D. Broide. 2007. Cytokines and growth factors in airway remodeling in asthma. Curr. Opin. Immunol. 19: 676-680. (Pubitemid 350236803)
3. + T helper cells engineered to produce latent TGF-β1 reverse allergen-induced airway hyperreactivity and inflammation. J. Clin. Invest. 105: 61-70.
4. Wahl, S. M., D. A. Hunt, H. L. Wong, S. Dougherty, N. McCartney-Francis, L. M. Wahl, L. Ellingsworth, J. A. Schmidt, G. Hall, A. B. Roberts, et al. 1988. Transforming growth factor-β is a potent immunosuppressive agent that inhibits IL-1-dependent lymphocyte proliferation. J. Immunol. 140: 3026-3032.
5. Fulkerson, P. C., C. A. Fischetti, L. M. Hassman, N. M. Nikolaidis, and M. E. Rothenberg. 2006. Persistent effects induced by IL-13 in the lung. Am. J. Respir. Cell Mol. Biol. 35: 337-346. (Pubitemid 44353402)
6. Balzar, S., H. W. Chu, P. Silkoff, M. Cundall, J. B. Trudeau, M. Strand, and S. Wenzel. 2005. Increased TGF-β2 in severe asthma with eosinophilia. J. Allergy Clin. Immunol. 115: 110-117. (Pubitemid 40075429)
7. Wills-Karp, M., and M. Chiaramonte. 2003. Interleukin-13 in asthma. Curr. Opin. Pulm. Med. 9: 21-27. (Pubitemid 35440966)
8. Wenzel, S. E., J. B. Trudeau, S. Barnes, X. Zhou, M. Cundall, J. Y. Westcott, K. McCord, and H. W. Chu. 2002. TGF-β and IL-13 synergistically increase eotaxin-1 production in human airway fibroblasts. J. Immunol. 169: 4613-4619. (Pubitemid 35178241)
9. Matsukura, S., C. Stellato, S. N. Georas, V. Casolaro, J. R. Plitt, K. Miura, S. Kurosawa, U. Schindler, and R. P. Schleimer. 2001. Interleukin-13 upregulates eotaxin expression in airway epithelial cells by a STAT6-dependent mechanism. Am. J. Respir. Cell Mol. Biol. 24: 755-761. (Pubitemid 32550599)
10. Hoeck, J., and M. Woisetschläger. 2001. STAT6 mediates eotaxin-1 expression in IL-4 or TNF-α-induced fibroblasts. J. Immunol. 166: 4507-4515. (Pubitemid 32233735)
11. Puxeddu, I., R. Bader, A. M. Piliponsky, R. Reich, F. Levi-Schaffer, and N. Berkman. 2006. The CC chemokine eotaxin/CCL11 has a selective profibrogenic effect on human lung fibroblasts. J. Allergy Clin. Immunol. 117: 103-110. (Pubitemid 43017147)
12. Humbles, A. A., D. M. Conroy, S. Marleau, S. M. Rankin, R. T. Palframan, A. E. Proudfoot, T. N. Wells, D. Li, P. K. Jeffery, D. A. Griffiths-Johnson, et al. 1997. Kinetics of eotaxin generation and its relationship to eosinophil accumulation in allergic airways disease: analysis in a guinea pig model in vivo. J. Exp. Med. 186: 601-612. (Pubitemid 27360804)
13. Li, D., D. Wang, D. A. Griffiths-Johnson, T. N. Wells, T. J. Williams, P. J. Jose, and P. K. Jeffery. 1997. Eotaxin protein and gene expression in guinea-pig lungs: constitutive expression and upregulation after allergen challenge. Eur. Respir. J. 10: 1946-1954. (Pubitemid 27406423)
14. Terada, N., N. Hamano, T. Nomura, T. Numata, K. Hirai, T. Nakajima, H. Yamada, O. Yoshie, T. Ikeda-Ito, and A. Konno. 2000. Interleukin-13 and tumour necrosis factor-α synergistically induce eotaxin production in human nasal fibroblasts. Clin. Exp. Allergy 30: 348-355. (Pubitemid 30167250)
15. Matsukura, S., M. Odaka, M. Kurokawa, H. Kuga, T. Homma, H. Takeuchi, K. Notomi, F. Kokubu, M. Kawaguchi, R. P. Schleimer, et al. 2010. Transforming growth factor-β stimulates the expression of eotaxin/CC chemokine ligand 11 and its promoter activity through binding site for nuclear factor-κB in airway smooth muscle cells. Clin. Exp. Allergy 40: 763-771.
16. Zuyderduyn, S., P. S. Hiemstra, and K. F. Rabe. 2004. TGF-β differentially regulates TH2 cytokine-induced eotaxin and eotaxin-3 release by human airway smooth muscle cells. J. Allergy Clin. Immunol. 114: 791-798. (Pubitemid 39330248)
17. Kumagai, N., K. Fukuda, Y. Ishimura, and T. Nishida. 2000. Synergistic induction of eotaxin expression in human keratocytes by TNF-α and IL-4 or IL-13. Invest. Ophthalmol. Vis. Sci. 41: 1448-1453. (Pubitemid 30261868)
18. Matsukura, S., C. Stellato, J. R. Plitt, C. Bickel, K. Miura, S. N. Georas, V. Casolaro, and R. P. Schleimer. 1999. Activation of eotaxin gene transcription by NF-κB and STAT6 in human airway epithelial cells. J. Immunol. 163: 6876-6883.
19. Liu, Y., C. Meyer, A. Müller, F. Herweck, Q. Li, R. Müllenbach, P. R. Mertens, S. Dooley, and H. L. Weng. 2011. IL-13 induces connective tissue growth factor in rat hepatic stellate cells via TGF-β-independent Smad signaling. J. Immunol. 187: 2814-2823.
20. Pannu, J., S. Nakerakanti, E. Smith, P. ten Dijke, and M. Trojanowska. 2007. Transforming growth factor-β receptor type I-dependent fibrogenic gene program is mediated via activation of Smad1 and ERK1/2 pathways. J. Biol. Chem. 282: 10405-10413. (Pubitemid 47093454)
21. Zheng, T., Z. Zhu, W. Liu, C. G. Lee, Q. Chen, R. J. Homer, and J. A. Elias. 2003. Cytokine regulation of IL-13Rα2 and IL-13Rα1 in vivo and in vitro. J. Allergy Clin. Immunol. 111: 720-728. (Pubitemid 36470239)
22. Chiaramonte, M. G., M. Mentink-Kane, B. A. Jacobson, A. W. Cheever, M. J. Whitters, M. E. Goad, A. Wong, M. Collins, D. D. Donaldson, M. J. Grusby, et al. 2003. Regulation and function of the interleukin 13 receptor α2 during a T helper cell type 2-dominant immune response. J. Exp. Med. 197: 687-701. (Pubitemid 36350864)
23. Hecker, M., Z. Zaslona, G. Kwapiszewska, G. Niess, A. Zakrzewicz, E. Hergenreider, J. Wilhelm, L. M. Marsh, D. Sedding, W. Klepetko, et al. 2010. Dysregulation of the IL-13 receptor system: a novel pathomechanism in pulmonary arterial hypertension. Am. J. Respir. Crit. Care Med. 182: 805-818.
24. Zhou, X., J. B. Trudeau, K. J. Schoonover, J. I. Lundin, S. M. Barnes, M. J. Cundall, and S. E. Wenzel. 2005. Interleukin-13 augments transforming growth factor-β1-induced tissue inhibitor of metalloproteinase-1 expression in primary human airway fibroblasts. Am. J. Physiol. Cell Physiol. 288: C435-C442. (Pubitemid 40105355)
25. Weinmann, A. S., and P. J. Farnham. 2002. Identification of unknown target genes of human transcription factors using chromatin immunoprecipitation. Methods 26: 37-47. (Pubitemid 34969216)
26. Nelson, J., O. Denisenko, and K. Bomsztyk. 2009. The fast chromatin immunoprecipitation method. Methods Mol. Biol. 567: 45-57.
27. Kotaru, C., K. J. Schoonover, J. B. Trudeau, M. L. Huynh, X. Zhou, H. Hu, and S. E. Wenzel. 2006. Regional fibroblast heterogeneity in the lung: implications for remodeling. Am. J. Respir. Crit. Care Med. 173: 1208-1215. (Pubitemid 43848390)
28. Atasoy, U., S. L. Curry, I. López de Silanes, A. B. Shyu, V. Casolaro, M. Gorospe, and C. Stellato. 2003. Regulation of eotaxin gene expression by TNF-α and IL-4 through mRNA stabilization: involvement of the RNA-binding protein HuR. J. Immunol. 171: 4369-4378. (Pubitemid 37238715)
29. Andrews, R. P., M. B. Ericksen, C. M. Cunningham, M. O. Daines, and G. K. Hershey. 2002. Analysis of the life cycle of stat6: continuous cycling of STAT6 is required for IL-4 signaling. J. Biol. Chem. 277: 36563-36569.
30. Elias, J. A., Z. Zhu, G. Chupp, and R. J. Homer. 1999. Airway remodeling in asthma. J. Clin. Invest. 104: 1001-1006.
31. Haldar, P., C. E. Brightling, B. Hargadon, S. Gupta, W. Monteiro, A. Sousa, R. P. Marshall, P. Bradding, R. H. Green, A. J. Wardlaw, and I. D. Pavord. 2009. Mepolizumab and exacerbations of refractory eosinophilic asthma. N. Engl. J. Med. 360: 973-984.
32. Castro, M., S. Mathur, F. Hargreave, L. P. Boulet, F. Xie, J. Young, H. J. Wilkins, T. Henkel, and P. Nair. 2011. Reslizumab for poorly controlled, eosinophilic asthma: a randomized, placebo-controlled study. Am. J. Respir. Crit. Care Med. 184: 1125-1132.
33. Flood-Page, P. T., A. N. Menzies-Gow, A. B. Kay, and D. S. Robinson. 2003. Eosinophil's role remains uncertain as anti-interleukin-5 only partially depletes numbers in asthmatic airway. Am. J. Respir. Crit. Care Med. 167: 199-204. (Pubitemid 36076080)
34. Mattoli, S., M. A. Stacey, G. Sun, A. Bellini, and M. Marini. 1997. Eotaxin expression and eosinophilic inflammation in asthma. Biochem. Biophys. Res. Commun. 236: 299-301. (Pubitemid 27373288)
35. Ahrens, R., A. Waddell, L. Seidu, C. Blanchard, R. Carey, E. Forbes, M. Lampinen, T.Wilson, E. Cohen, K. Stringer, et al. 2008. Intestinal macrophage/ epithelial cell-derived CCL11/eotaxin-1 mediates eosinophil recruitment and function in pediatric ulcerative colitis. J. Immunol. 181: 7390-7399.
36. Hirst, S. J., M. P. Hallsworth, Q. Peng, and T. H. Lee. 2002. Selective induction of eotaxin release by interleukin-13 or interleukin-4 in human airway smooth muscle cells is synergistic with interleukin-1β and is mediated by the interleukin-4 receptor α-chain. Am. J. Respir. Crit. Care Med. 165: 1161-1171. (Pubitemid 34415828)
37. Yang, M., S. P. Hogan, P. J. Henry, K. I. Matthaei, A. N. McKenzie, I. G. Young, M. E. Rothenberg, and P. S. Foster. 2001. Interleukin-13 mediates airways hyperreactivity through the IL-4 receptor-α chain and STAT-6 independently of IL- 5 and eotaxin. Am. J. Respir. Cell Mol. Biol. 25: 522-530. (Pubitemid 33037686)
38. Chung, K. F., H. J. Patel, E. J. Fadlon, J. Rousell, E. B. Haddad, P. J. Jose, J. Mitchell, and M. Belvisi. 1999. Induction of eotaxin expression and release from human airway smooth muscle cells by IL-1β and TNFα: effects of IL-10 and corticosteroids. Br. J. Pharmacol. 127: 1145-1150. (Pubitemid 29326637)
39. Zhu, Z., R. J. Homer, Z. Wang, Q. Chen, G. P. Geba, J. Wang, Y. Zhang, and J. A. Elias. 1999. Pulmonary expression of interleukin-13 causes inflammation, mucus hypersecretion, subepithelial fibrosis, physiologic abnormalities, and eotaxin production. J. Clin. Invest. 103: 779-788. (Pubitemid 29152623)
40. Li, L., Y. Xia, A. Nguyen, Y. H. Lai, L. Feng, T. R. Mosmann, and D. Lo. 1999. Effects of Th2 cytokines on chemokine expression in the lung: IL-13 potently induces eotaxin expression by airway epithelial cells. J. Immunol. 162: 2477-2487. (Pubitemid 29309264)
41. Takeda, K., T. Tanaka, W. Shi, M. Matsumoto, M. Minami, S. Kashiwamura, K. Nakanishi, N. Yoshida, T. Kishimoto, and S. Akira. 1996. Essential role of Stat6 in IL-4 signalling. Nature 380: 627-630. (Pubitemid 26119015)
42. Hein, H., C. Schlüter, R. Kulke, E. Christophers, J. M. Schröder, and J. Bartels. 1997. Genomic organization, sequence, and transcriptional regulation of the human eotaxin gene. Biochem. Biophys. Res. Commun. 237: 537-542. (Pubitemid 27434720)
43. Yoshikawa, M., T. Nakajima, T. Tsukidate, K. Matsumoto, M. Iida, N. Otori, S. Haruna, H. Moriyama, and H. Saito. 2003. TNF-α and IL-4 regulate expression of IL-13 receptor α2 on human fibroblasts. Biochem. Biophys. Res. Commun. 312: 1248-1255. (Pubitemid 37490951)
44. David, M., D. Ford, J. Bertoglio, A. L. Maizel, and J. Pierre. 2001. Induction of the IL-13 receptor α2-chain by IL-4 and IL-13 in human keratinocytes: involvement of STAT6, ERK and p38 MAPK pathways. Oncogene 20: 6660-6668. (Pubitemid 33020595)
45. Moynihan, B. J., B. Tolloczko, S. El Bassam, P. Ferraro, M. C. Michoud, J. G. Martin, and S. Laberge. 2008. IFN-γ, IL-4 and IL-13 modulate responsiveness of human airway smooth muscle cells to IL-13. Respir. Res. 9: 84.
46. Lee, M. K., C. Pardoux, M. C. Hall, P. S. Lee, D. Warburton, J. Qing, S. M. Smith, and R. Derynck. 2007. TGF-β activates Erk MAP kinase signalling through direct phosphorylation of ShcA. EMBO J. 26: 3957-3967. (Pubitemid 47367487)
47. Moore, P. E., T. L. Church, D. D. Chism, R. A. Panettieri, Jr., and S. A. Shore. 2002. IL-13 and IL-4 cause eotaxin release in human airway smooth muscle cells: a role for ERK. Am. J. Physiol. Lung Cell. Mol. Physiol. 282: L847-L853. (Pubitemid 34665602)
48. Scherf, W., S. Burdach, and G. Hansen. 2005. Reduced expression of transforming growth factor β1 exacerbates pathology in an experimental asthma model. Eur. J. Immunol. 35: 198-206. (Pubitemid 40123866)
49. Ray, A., A. Khare, N. Krishnamoorthy, Z. Qi, and P. Ray. 2010. Regulatory T cells in many flavors control asthma. Mucosal Immunol. 3: 216-229.
50. Han, Y., T. Meng, N. R. Murray, A. P. Fields, and A. R. Brasier. 1999. Interleukin- 1-induced nuclear factor-κB-IκBα autoregulatory feedback loop in hepatocytes: a role for protein kinase cα in post-transcriptional regulation of iκbα resynthesis. J. Biol. Chem. 274: 939-947.
51. de Waal Malefyt, R., J. Abrams, B. Bennett, C. G. Figdor, and J. E. de Vries. 1991. Interleukin 10 (IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes. J. Exp. Med. 174: 1209-1220.
52. Franchimont, N., S. Rydziel, and E. Canalis. 1997. Interleukin 6 is autoregulated by transcriptional mechanisms in cultures of rat osteoblastic cells. J. Clin. Invest. 100: 1797-1803. (Pubitemid 27431338)